Independence Blue Cross settles MA diagnosis-retention allegations for $22.5 million
Oct 11, 2026 edition · GC-2026-0167 · Published 2026-10-11 · Version 4 · Settled
Independence Blue Cross agreed to pay $22.5 million over allegations that it retained Medicare Advantage overpayments linked to unsupported diagnoses. DOJ describes chart reviews used to add diagnoses while failing to withdraw others. The settlement resolves allegations without a liability determination.
What happened
DOJ’s September 30 announcement describes a $22.5 million False Claims Act settlement with Independence Blue Cross. The government alleged that IBX submitted inaccurate diagnosis data for Medicare Advantage enrollees, failed to withdraw that data and repay associated overpayments, and falsely certified its accuracy. Medicare Advantage organizations receive monthly payments adjusted for factors affecting expected healthcare costs. Diagnosis codes therefore influence the payment amount, making the correction or deletion of unsupported data financially significant as well as a coding-control issue.
For payment years 2017 through 2021, the government contends that nurse chart reviewers identified conditions supporting additional diagnosis submissions, while some previously submitted diagnoses were not substantiated. IBX allegedly used the reviews to seek more payment but did not delete unsupported diagnoses when the same work indicated overpayment. The settlement also resolves a former employee’s whistleblower lawsuit, with a $3.825 million share reported for that individual. DOJ states that the resolved claims are allegations and that liability was not determined. The case illustrates the risk of one-sided chart-review workflows; it is not a new CMS coding rule or proof that every disputed diagnosis was fraudulent.
Scope and timing
- Authority status
- Settled
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
Why it matters
MA chart-review controls must handle unsupported diagnoses as well as additions. The settlement is historical enforcement, not a newly issued coding rule or a universal repayment demand.
Recommended action
Risk Adjustment, Compliance and Finance should test whether contrary chart-review findings reach diagnosis withdrawal and overpayment workflows, with documented escalation and reconciliation.
Case details
- agencies
- U.S. Department of Justice
- entities
- Independence Blue Cross
- action Type
- Settlement
- event Date
- 2026-09-30
- alleged Conduct
- Alleged retention of MA overpayments tied to inaccurate diagnosis codes.
- resolution
- Civil settlement; the allegations are not a trial judgment.
Operational lessons
- Sample risk-adjustment deletions, chart-review escalation and overpayment disposition. Confirm that unsupported diagnoses found after submission trigger the applicable correction and repayment analysis.
Sources
- Independence Blue Cross to pay $22.5 million to resolve FCA allegationsOfficial · DOJ · 2026-09-30 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →